36.24
Precedente Chiudi:
$36.46
Aprire:
$36.69
Volume 24 ore:
880.18K
Relative Volume:
0.49
Capitalizzazione di mercato:
$4.68B
Reddito:
-
Utile/perdita netta:
$-507.65M
Rapporto P/E:
-7.8783
EPS:
-4.6
Flusso di cassa netto:
$-616.24M
1 W Prestazione:
-3.02%
1M Prestazione:
+6.31%
6M Prestazione:
-59.57%
1 anno Prestazione:
-57.44%
Vaxcyte Inc Stock (PCVX) Company Profile
Nome
Vaxcyte Inc
Settore
Industria
Telefono
650-837-0111
Indirizzo
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Confronta PCVX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PCVX
Vaxcyte Inc
|
36.24 | 4.70B | 0 | -507.65M | -616.24M | -4.60 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
2024-12-20 | Iniziato | Goldman | Buy |
2023-12-07 | Iniziato | Mizuho | Buy |
2023-04-18 | Iniziato | TD Cowen | Outperform |
2023-01-03 | Reiterato | Needham | Buy |
2022-12-15 | Iniziato | Guggenheim | Buy |
2022-11-17 | Iniziato | BTIG Research | Buy |
2021-12-29 | Ripresa | Jefferies | Buy |
2021-06-24 | Ripresa | Jefferies | Buy |
2020-07-07 | Iniziato | BofA Securities | Buy |
2020-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
2020-07-07 | Iniziato | Needham | Buy |
Mostra tutto
Vaxcyte Inc Borsa (PCVX) Ultime notizie
What drives Vaxcyte Inc. stock priceExceptional profit margins - Autocar Professional
Vaxcyte Inc. Stock Analysis and ForecastRapid market gains - jammulinksnews.com
What analysts say about Vaxcyte Inc. stockRemarkable growth - jammulinksnews.com
Is Vaxcyte Inc. a good long term investmentBreakout profit opportunities - Autocar Professional
Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX) - MSN
Nisa Investment Advisors LLC Buys 293 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com
Vaxcyte’s High-Stakes Bet On Next-Gen Pneumonia Vaccines - Finimize
What makes Vaxcyte Inc. stock price move sharplyBreakout Momentum Stocks - beatles.ru
Why Vaxcyte Inc. stock attracts strong analyst attentionBig Profit Small Risk Alerts - Newser
How Vaxcyte Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser
Teacher Retirement System of Texas Sells 2,779 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Here’s Why Vaxcyte (PCVX) Sold Off in Q1 - Insider Monkey
(PCVX) Trading Advice - news.stocktradersdaily.com
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting - MSN
Vaxcyte (PCVX): Riding Passive Fund Winds to FDA Catalysts – A Tactical Play with Strategic Upside - AInvest
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2500 Value Index - MarketScreener
Vaxcyte (PCVX): Riding Clinical Catalysts Against a Stormy Regulatory Tide - AInvest
Vaxcyte Holds Annual Stockholders Meeting on Governance - TipRanks
How To Trade (PCVX) - news.stocktradersdaily.com
Cantor Fitzgerald Estimates Vaxcyte FY2026 Earnings - Defense World
Transcript : Vaxcyte, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener
Vaxcyte Inc Azioni (PCVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):